Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00334451 · ClinicalTrials.gov registry record
RAPID-RF: Remote Active Monitoring in Patients With Heart Failure
A clinical trial, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- 891
- Enrollment target
NCT00334451 is a clinical trial that has completed, run by Boston Scientific Corporation. The registered enrollment target is 891 participants.
The verdict
NCT00334451 has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- 891 participants
- Enrollment target
Study Summary
The RAPID-RF Registry aims to characterize LATITUDE® Patient Management's alert feature: LATITUDE Active Monitoring™ by evaluating type and frequency of alert notifications and alert-related medical interventions. This registry will also assess clinical outcomes including quality of life and New York Heart Association Class changes over time, mortality, hospitalizations and heart failure-related event rates.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 891 participants |
| Start Date | 2006-05 |
| Est. Completion | 2008-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00334451
The ClinicalTrials.gov registry entry for NCT00334451 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 891 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00334451 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00334451 about?
NCT00334451 is a clinical study titled "RAPID-RF: Remote Active Monitoring in Patients With Heart Failure". The RAPID-RF Registry aims to characterize LATITUDE® Patient Management's alert feature: LATITUDE Active Monitoring™ by evaluating type and frequency of alert notifications and alert-related medical interventions. This registry will also assess clinical outcomes including quality of life and New Yor...
What is the current status of trial NCT00334451?
This trial is currently completed. The enrollment target is 891 participants. The study started on 2006-05. Estimated completion is 2008-07.
Who is sponsoring clinical trial NCT00334451?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.